Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 87530 refers to the detection of infectious agents through nucleic acid techniques, specifically focusing on the quantification of the Herpes simplex virus (HSV). This procedure utilizes either DNA or RNA to identify the presence of HSV, which is a virus that can cause significant health issues, particularly in vulnerable populations such as neonates and immunocompromised individuals. The quantification process provides valuable information regarding the viral load, which can be crucial for assessing the severity of the infection and monitoring the effectiveness of treatment interventions. Herpes simplex virus is transmitted primarily through direct contact, and the initial infection often manifests as ulcerations on the skin or mucous membranes. Following this primary infection, the virus can enter a latent state, reactivating under certain conditions such as stress or illness. There are two distinct types of HSV: type 1, which is commonly associated with oral herpes (cold sores) but can also lead to genital infections, and type 2, which primarily causes genital herpes. The testing process involves obtaining a specimen from various sources, including oral or genital lesions, vitreous fluid from the eye, or blood samples. The quantification of HSV through this code is essential for understanding the dynamics of the infection and guiding clinical decisions.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 87530 is indicated for the detection and quantification of the Herpes simplex virus (HSV) in patients who may present with symptoms or conditions related to HSV infection. The following are specific indications for performing this procedure:
The procedure for CPT® Code 87530 involves several critical steps to ensure accurate detection and quantification of the Herpes simplex virus. The following outlines the procedural steps:
After the procedure associated with CPT® Code 87530, it is important to consider the following aspects of post-procedure care and follow-up:
Patients may require counseling regarding the implications of their test results, particularly if quantification indicates a high viral load. This information can guide further treatment decisions and monitoring strategies. Additionally, healthcare providers should ensure that patients understand the importance of follow-up appointments to assess treatment efficacy and manage any potential complications associated with HSV infection. Regular monitoring may be necessary for individuals with recurrent infections or those at higher risk for severe disease.
| Short Descr | HSV DNA QUANT | Medium Descr | IADNA HERPES SOMPLX VIRUS QUANTIFICATION | Long Descr | Infectious agent detection by nucleic acid (DNA or RNA); Herpes simplex virus, quantification | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 2 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | GW | Service not related to the hospice patient's terminal condition | GZ | Item or service expected to be denied as not reasonable and necessary | XS | Separate structure, a service that is distinct because it was performed on a separate organ/structure | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| 1998-01-01 | Added | First appearance in code book in 1998. |
Get instant expert-level medical coding assistance.